Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | VEGF | 444.0 | 56 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | VEGF | 657.0 | 59 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | VEGF | 580.0 | 81 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | VEGF | 450.0 | 51 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | VEGF | 738.0 | 55 | ||||
RA2159 | 2 | VEGF | 712.5 | 54 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | VEGF | 732.0 | 53 | ||||
N2645 | 2 | VEGF | 955.0 | 79 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | VEGF | 742.0 | 49 | ||||
RA2708 | 2 | VEGF | 784.0 | 51 | |||||||
0 | VEGF | 40.0 | 47 | ||||||||
0 | VEGF | 45.0 | 46 | ||||||||
0 | VEGF | 47.0 | 51 | ||||||||
0 | VEGF | 50.0 | 67 | ||||||||
0 | VEGF | 46.0 | 51 | ||||||||
0 | VEGF | 51.0 | 39 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 692.0 | 61 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | VEGF | 891.0 | 69 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 961.5 | 56 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | VEGF | 873.0 | 79 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 889.5 | 84 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | VEGF | 1101.5 | 76 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 1035.0 | 82 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | VEGF | 892.5 | 62 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | VEGF | 1253.0 | 70 |